Health Care & Life Sciences » Healthcare Provision | Venn Life Sciences Holdings PLC

Venn Life Sciences Holdings PLC | Balance Sheet

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
450.10
625.50
2,900.20
3,022.60
1,043.00
Total Accounts Receivable
488.40
966.20
4,013.80
2,285.10
3,285.30
Other Current Assets
100.70
686.00
-
1,509.20
2,023.90
Total Current Assets
1,039.10
2,277.70
6,914.00
6,816.80
6,352.20
Net Property, Plant & Equipment
44.10
150.60
280.80
163.00
277.00
Total Investments and Advances
25.80
24.10
22.80
26.50
27.50
Intangible Assets
864.40
2,188.50
4,007.20
3,840.30
3,580.90
Other Assets
-
-
-
1,713.20
603.60
Total Assets
1,973.40
4,640.80
11,224.90
12,559.90
10,841.20
ST Debt & Current Portion LT Debt
270.40
227.40
25.80
29.90
22.20
Accounts Payable
346.10
506.80
740.00
904.80
1,038.60
Income Tax Payable
14.10
210.30
510.00
478.90
385.30
Other Current Liabilities
698.00
2,221.00
2,368.80
2,220.20
1,623.60
Total Current Liabilities
1,328.70
3,165.50
3,644.60
3,633.80
3,069.60
Long-Term Debt
-
76.80
38.30
21.30
-
Other Liabilities
44.90
-
-
-
-
Total Liabilities
1,373.60
3,242.30
3,682.90
3,655.10
3,069.60
Common Equity (Total)
599.90
976.30
7,301.00
8,904.70
7,771.60
Total Shareholders' Equity
599.90
976.30
7,301.00
8,904.70
7,771.60
Total Equity
599.90
1,398.40
7,542.00
8,904.70
7,771.60
Liabilities & Shareholders' Equity
1,973.40
4,640.80
11,224.90
12,559.90
10,841.20
Accumulated Minority Interest
-
422.20
241.00
-
-

About Venn Life Sciences Holdings

View Profile
Address
19 Railway Road
Dublin Dublin
Ireland
Employees -
Website http://www.vennlifesciences.com
Updated 09/14/2018
Venn Life Sciences Holdings Plc is a clinical research organization, which provides a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. Its services include drug development planning and strategy, early drug development, clinical monitoring, medical monitoring, investigator initiated studies, clinical feasibility assessment, regulatory affairs and consulting, quality assurance, and drug development training and courses. The company is headquartered in Dublin, Ireland.